| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |